First Human Trials Raise Plandai's Profile and Valuation

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
First Human Trials Raise Plandai's Profile and Valuation

BALTIMORE, MD--(Marketwired - Jul 23, 2013) - Goldman Small Cap Research, a stock market research firm focused on the small cap and microcap sectors, released a research update on Plandai Biotechnology Inc.'s ( OTCQB : PLPL ). Goldman Small Cap Research believes that by engaging in the upcoming human clinical trials for its flagship product, trials, Plandai has the opportunity to be crowned the Green Tea Extract and bioavailability leader. Furthermore, Goldman notes that the likely favorable results of the trial should enable the Firm to successfully market its product to manufacturers for use in health prevention and wellness, beginning in late 2013.

The Company's upcoming study with KGK will be the first that tests the absorption properties of the Plandai green-tea based Catechin Complex in human subjects. The bioavailability study will not only test the absorption of Phytofare™ Catechin Complex, but it will compare Phytofare™ against a generic green tea extract and a branded product that touts higher bioavailability. In addition, Plandai has also contracted with KGK to simultaneously perform a human weight loss trial to test the effects of Phytofare™ Catechin Complex in inducing weight loss while also improving cholesterol and lowering blood pressure.

In the Goldman Opportunity Research update on the Company, analyst Rob Goldman outlines his investment thesis.

"We believe that the upcoming weight loss trial may be even more important than the traditional trial, given the size of the market for products used in weight loss and the fight against high blood pressure. A number of human clinical trials with green tea extract have been conducted to this end, and while data has been positive, the lack of bioavailability has halted broad use of these products for these applications. In our view, these huge milestone events raise the Company's profile and should substantially increase the Firm's valuation."

Goldman Small Cap Research articles and reports on Plandai as well as associated disclaimers can be accessed or downloaded in their entirety by visiting www.goldmanresearch.com .

About Goldman Small Cap Research: Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces small cap and micro cap stock research reports, daily stock market blogs, and popular investment newsletters. For more information, visit www.goldmanresearch.com .

A Goldman Small Cap Research report is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. Please read the report's full disclosures and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other agency. To download our research, view our disclosures, or for more information, visit www.goldmanresearch.com .

About Plandai Biotechnology, Inc. ( OTCQB : PLPL ): Plandai Biotechnology, Inc. and its subsidiaries develop highly bioavailable, phytonutrient rich extracts, which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions. Plandai Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing the patented Phytofare™ extracts in-house allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include food and beverage, cosmeceutical, wellness, nutraceutical, anti-aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com .

Goldman Small Cap Research Rob Goldman Analyst 410-609-7100 rob@goldmanresearch.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Zika Virus: A Surprising Ally in Brain Cancer Fight

Updated Category News Views 6

Here’s something you don’t hear every day: using a virus that typically targets the brain not as a foe, but as a formidable ally in the war against glioblastoma. It’s a gutsy play by UP Oncolytics, a scrappy biotech outfit cradled within Rosalind Franklin University’s Helix 51 incubator. Risky Bet on a Known Adversary Glioblastoma—a real beast in the cancer...

Continue Reading
Food Trends Tease: 2027 sofi™ Awards' 75 Finalists

Updated Category News Views 5

The Specialty Food Scene Heats Up Today’s world doesn’t rest when it comes to innovation, and the same goes for the tantalizing realm of specialty foods. Hot off the press, the Specialty Food Association (SFA) just rolled out the red carpet for its 75 finalists in the 2027 sofi™ Awards. These are the future taste shapers set to take center stage at the Winter...

Continue Reading
Steel Dynamics' Q3 2026: Record Shipments Boost Profits

Updated Category News Views 3

Steel Dynamics Shatters Records in Q3 2026 If there was any doubt about Steel Dynamics' ability to ride the waves in the steel and aluminum market, the third quarter of 2026 put that to rest. With a record-breaking 3.8 million tons of steel shipped and net sales reaching a steep $6.5 billion, this isn't just business as usual—it's smashing their own ceiling. Operating...

Continue Reading
Understanding Truck Accident Settlements in Memphis

Updated Category News Views 9

Delving into Truck Accident Settlement Timelines Out there in Memphis, timing a truck accident settlement isn't exactly like clockwork work. When it comes to getting your compensation, the timeline varies as widely as a duck hunting trip—sometimes you come home with a basketful, sometimes it’s empty. It might be a quick couple of months or drag on past a year, and...

Continue Reading
AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Updated Category News Views 12

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Continue Reading
Cruise Planners Sets AI Benchmark in Travel Innovs

Updated Category News Views 10

Unveiling the AI Arsenal of Cruise Planners Alright, listen up, folks. When you think about travel and tech, Cruise Planners ain't just dipping a toe—they're cannonballing right in, splashing everyone around with their shiny new AI tricks. Twenty-three. That's how many innovations they're flaunting this year. It's like they're running a tech marathon, and boy, are they...

Continue Reading
OppFi Readies Q3 Earnings; Investors Eye Financials

Updated Category News Views 6

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Continue Reading
Cancer Memoir Shows Healing Beyond Medicine

Updated Category News Views 13

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Continue Reading
Ruth E. Carter Returns Home with Celebrated Exhibition

Updated Category News Views 7

Ruth E. Carter’s Triumphant Return When a titan of the costume design world circles back to their roots, you know it’s bound to be something special. Ruth E. Carter, who has swapped needles and threads for Oscars (twice, mind you), is making a return to Hampton University, paying homage to the very soil that sowed her artistic seeds. Ain't that a capstone of a career...

Continue Reading
Art Print Paper: Finding the Perfect Match for Masterpieces

Updated Category News Views 13

You ever stand in a gallery and notice how some art just lights up the room while others barely get a second glance? Well, a lot of that magic starts with an unsung hero—paper choice. I came across this bit from HelloNation diving into what makes paper selection a cornerstone for fine art prints. Now, I ain't an artist, but even a bruiser trader like me can see the...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding China’s Continuous Fight Against Corruption

Updated Category News Views 130

China's Unwavering Commitment to Anti-Corruption The ongoing anti-corruption campaign in China has captured global attention, revealing a unique approach that contrasts sharply with Western models. Chinese leadership emphasizes the importance of strict governance to build trust and maintain integrity within the Party. Leadership and Governance The Political Bureau of the...

Continue Reading
Celularity Takes Steps to Address Nasdaq Filing Compliance Issues

Updated Category News Views 168

Celularity's Nasdaq Notification and Response Celularity Inc. (Nasdaq: CELU), a leader in regenerative and cellular medicine, recently received important communication from Nasdaq regarding its filing obligations. The company was informed that it did not file its Quarterly Report on Form 10-Q on time for the period ending June 30, 2025. This communication has significant...

Continue Reading
Scott Armul Takes the Helm as Executive VP at Vertiv Holdings

Updated Category News Views 126

Scott Armul Promoted to Executive Vice President Vertiv Holdings Co (NYSE: VRT), a leader in critical digital infrastructure and continuity solutions, has made a significant move by promoting Scott Armul to the position of executive vice president for global portfolio and business units. This decision is effective from January 1, 2025, marking a pivotal point in the...

Continue Reading
California's New Climate Superfund: A Game Changer for Residents

Updated Category News Views 255

California's Innovative Climate Superfund Initiative In an ambitious effort to enhance its budget while tackling climate change, California has proposed a groundbreaking plan—AB 1243 and SB 684, known as the Polluters Pay Climate Superfund Act. Aimed at holding the world's largest fossil fuel companies accountable, this legislation seeks to alleviate financial burdens...

Continue Reading
New Fortress Energy Inc. Faces Class Action Amid Share Drop

Updated Category News Views 46

New Fortress Energy Inc. Faces Class Action Amid Share Drop Investors in New Fortress Energy Inc. should be aware of a significant legal development. A class action lawsuit has been initiated in the U.S. District Court for the Southern District, aimed at protecting the rights of shareholders who purchased company securities during a specified time frame. This lawsuit has...

Continue Reading